tauro-a-muricholic acid

Tauro-β-muricholic Acid sodium is a endogenous metabolite, is a competitive and reversible antagonist of farnesoid X receptor (FXR)(IC50 of 40 μM).

Tauro-α-muricholic acid (TαMCA) is an antagonist of the farnesoid X receptor (FXR; IC50 = 28 μM) and a taurine-conjugated form of the murine-specific primary bile acid α-muricholic acid . TαMCA is common in rodents but has also been found in small amounts in human serum.

Tauro-ω-muricholic acid sodium (TωMCA sodium) is an analogue of tauro-α-muricholic acid, a bile acid derived from the liver. TωMCA sodium can serve as a serum marker for early onset neonatal sepsis (EOS) and biliary stasis.

Tauro-β-muricholic acid (TβMCA), a trihydroxylated bile acid, serves as a competitive and reversible FXR antagonist (IC50 = 40 μM) and demonstrates antiapoptotic effects by preventing bile acid-induced hepatocellular apoptosis and maintaining mitochondrial membrane potential [1][2].

Tauro-β-muricholic acid sodium (Standard) is a reference standard for research and analysis in studies involving Tauro-β-muricholic acid sodium. Tauro-β-muricholic Acid sodium is a endogenous metabolite, is a competitive and reversible antagonist of farnesoid X receptor (FXR)(IC50 of 40 μM).

Tauro-α-muricholic Acid (sodium salt) (Standard) is a reference standard for research and analysis in studies involving Tauro-α-muricholic Acid (sodium salt). Tauro-α-muricholic acid (TαMCA) is an antagonist of the farnesoid X receptor (FXR; IC50 = 28 μM) and a taurine-conjugated form of the murine-specific primary bile acid α-muricholic acid . TαMCA is common in rodents but has also been found in small amounts in human serum.

Tauro-ω-Muricholic Acid Sodium Salt (Standard) is a reference standard of Tauro-ω-Muricholic Acid Sodium Salt intended for quantitative analysis, quality control, and related biochemical research applications.